Multitarget Drug Design
- At: 2013 FIP Congress in Dublin (Ireland)
- Type: Presentation
- By: HOLZGRABE, Ulrike (University of Wuerzburg, Institute of Pharmacy, Wuerzburg, Germany)
For dozens of years the 'one drug- one target' paradigm has been challenged because the medicinal chemists strongly believed that this is the only way to avoid adverse drug reactions. Large screening panel were employed to recognize all possible off-target activities. On the other hand pharmacologists were aware of the fact that the effectiveness.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.